//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
The 4th Gordon Research Conference & Seminar on Venom Evolution, Function and Biomedical Applications - 16-17 (GRS) 17-22 (GRC) May, 2026! #Barcelona #GRCVenom26 #GRSVenom26
GRC Venoms









Loading...
Earlier this year, she co-authored a review showing how “recombinant antivenoms” (built from defined antibodies rather than animal blood products) are increasingly moving from theory into practical possibility tandfonline.com/.../10.../17...
6mo
Dr. Mark J. Margres (margreslab.com) is an Assistant Professor in the Department of Integrative Biology at @usf.edu
And more recently, she contributed to a major breakthrough: a new nanobody-based antivenom that neutralises toxins from many African elapid snakes (cobras, mambas, rinkhals, etc), offering a more consistent, scalable & ethical alternative to conventional serum-derived antivenoms.
Mark's venom work has consistently been at the forefront of the field, focusing on causes and consequences of intra- and interspecific venom variation in snakes through the application of cutting-edge genomic approaches.
Dr. Margres' research group studies coevolutionary interactions between venomous predators and their prey, as well as between transmissible cancers and their Tasmanian devil hosts.
We're looking forward to Stefanie speaking in our "Tools and Methods in Toxinology Research" session at #GRCVenom26
Her team uses modern lab-based methods — including antibody display technologies — to isolate and engineer monoclonal antibodies capable of neutralising snake venom toxins.
7mo
6mo
7mo
7mo
6mo
6mo
GRC Venoms
Dr Stefanie Menzies is a Lecturer in Molecular Cell Biology at @lancasteruni.bsky.social and leads the @menzieslab.bsky.social, which works on developing new treatments and diagnostics for snakebite and other global-health threats.
Dr. Margres' full publication list can be found here: scholar.google.com/citations?us..., and he will be speaking in our "Characterizing Coevolution and Toxin-Target Interactions" session at #GRCVenon26
Dr. Margres and colleagues recently studied island rattlesnakes in the Gulf of California and found that the number of sympatric congenerics, degree of island isolation, and island area all significantly and negatively correlated with venom complexity doi.org/10.1093/evol...
7mo
6mo
7mo
GRC Venoms
GRC Venoms
GRC Venoms
GRC Venoms
GRC Venoms
GRC Venoms
GRC Venoms
GRC Venoms
GRC Venoms